Substance / Medication

Brompheniramine

Overview

Active Ingredient
brompheniramine
RxNorm CUI
1767

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Extra- and intracellular formation of reactive oxygen species by human neutrophils in the presence of pheniramine, chlorpheniramine and brompheniramine.
Jancinová Viera, Drábiková Katarína, Nosál' Radomír et al. · Neuro Endocrinol Lett · 2006
PMID: 17159800Observational
Analytical methods for the determination of paracetamol, pseudoephedrine and brompheniramine in Comtrex tablets.
Youssef Souha Hosam, Mohamed Dalia, Hegazy Maha Abdel Monem et al. · BMC Chem · 2019
PMID: 31384825OtherFull text (PMC)
Brompheniramine as a novel probe for indirect UV detection and its application for the capillary electrophoresis of adamantane drugs.
Prapatpong Pornpan, Prutthiwanasan Brompoj, Nuchtavorn Nantana et al. · J Sep Sci · 2017
PMID: 28087893Other
Complementary fluorescence and phosphorescence study of the interaction of brompheniramine with human serum albumin.
Tardioli Silvia, Lammers Ivonne, Hooijschuur Jan-Hein et al. · J Phys Chem B · 2012
PMID: 22612655Other
Chemometric evaluation of brompheniramine-tannate complexes.
Zidan Ahmed S, Rahman Ziyaur, Khan Mansoor A · J Pharm Sci · 2012
PMID: 22213440Other
Bioavailability assessment of a brompheniramine taste-masked pediatric formulation in a juvenile porcine model.
Wang Jiang, Shakleya Diaa, Giacoia George et al. · Biomed Chromatogr · 2024
PMID: 38412513Preclinical
Subcutaneous brompheniramine for cutaneous analgesia in rats.
Chiu Chong-Chi, Chen Jen-Yin, Chen Yu-Wen et al. · Eur J Pharmacol · 2019
PMID: 31319069Preclinical
Brompheniramine and Chlorpheniramine Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years.
Pathirana Sudam, Jayawardena Shyamalie, Meeves Suzanne et al. · J Clin Pharmacol · 2018
PMID: 29136286Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Brompheniramine (substance)
SNOMED CT
372775001
UMLS CUI
C0006246
RxNorm CUI
1767

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.